Cargando…
Polyamine–Drug Conjugates: Do They Boost Drug Activity?
Over the past two decades, the strategy of conjugating polyamine tails with bioactive molecules such as anticancer and antimicrobial agents, as well as antioxidant and neuroprotective scaffolds, has been widely exploited to enhance their pharmacological profile. Polyamine transport is elevated in ma...
Autores principales: | Basagni, Filippo, Marotta, Giambattista, Rosini, Michela, Minarini, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254200/ https://www.ncbi.nlm.nih.gov/pubmed/37298993 http://dx.doi.org/10.3390/molecules28114518 |
Ejemplares similares
-
Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
por: Marotta, Giambattista, et al.
Publicado: (2020) -
Exploring the activity of polyamine analogues on polyamine and spermine oxidase: methoctramine, a potent and selective inhibitor of polyamine oxidase
por: Di Paolo, Maria Luisa, et al.
Publicado: (2019) -
Polyamine Conjugation as a Promising Strategy To Target
Amyloid Aggregation in the Framework of Alzheimer’s Disease
por: Simoni, Elena, et al.
Publicado: (2016) -
From Monoamine Oxidase Inhibition to Antiproliferative Activity: New Biological Perspectives for Polyamine Analogs
por: Nordio, Giulia, et al.
Publicado: (2023) -
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes
por: Basagni, Filippo, et al.
Publicado: (2020)